Ancora.ai connects patients to clinical trials

Ancora.ai AG

Incorporated

30.06.2020

Headquarters

Zurich

Support

Finding a clinical trial for a cancer patient demands extraordinary effort as it requires evaluating many available trial opportunities against specific patient characteristics. Ancora.ai accelerates clinical trial recruitment by systematically and seamlessly connecting patients to trials. Our proprietary technology structures jargon-laden clinical trial protocols into an easy to use interface to match any patient to trials at scale. Our best-in-class trial matching solution means we can more efficiently and effectively match highly qualified patients to the right trials, thereby transforming the $44B. clinical research industry to be data-driven & enabling precision medicine recruitment.